




Searching News Database: Contrast-Induced Nephropathy
HSMN NewsFeed - 14 Oct 2011
PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
HSMN NewsFeed - 4 May 2009
PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
HSMN NewsFeed - 26 Nov 2008
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
HSMN NewsFeed - 30 May 2008
PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
HSMN NewsFeed - 28 Mar 2008
PLC Systems Announces First International Distribution Agreement for RenalGuard(TM)
PLC Systems Announces First International Distribution Agreement for RenalGuard(TM)
HSMN NewsFeed - 20 Mar 2008
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
HSMN NewsFeed - 29 Aug 2007
FlowMedica Announces Completion of the Benephit System Renal Infusion Therapy (Be-RITe) Registry
FlowMedica Announces Completion of the Benephit System Renal Infusion Therapy (Be-RITe) Registry
HSMN NewsFeed - 17 Jul 2007
FlowMedica, Inc. Appoints Gary Saxton as President and Chief Executive Officer
FlowMedica, Inc. Appoints Gary Saxton as President and Chief Executive Officer
HSMN NewsFeed - 16 Mar 2007
First Patients Treated In RenalGuard(TM) Investigational Study By PLC Medical Systems
First Patients Treated In RenalGuard(TM) Investigational Study By PLC Medical Systems
Additional items found! 2

Members Archive contains
2 additional stories matching:
Contrast-Induced Nephropathy
(Password required)
Contrast-Induced Nephropathy
(Password required)